List of Excipients in API ENTRECTINIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ENTRECTINIB
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | ROZLYTREK | entrectinib | 50242-091 | ANHYDROUS LACTOSE | 2038-07-18 |
| Genentech Inc | ROZLYTREK | entrectinib | 50242-091 | CELLULOSE, MICROCRYSTALLINE | 2038-07-18 |
| Genentech Inc | ROZLYTREK | entrectinib | 50242-091 | CROSPOVIDONE | 2038-07-18 |
| Genentech Inc | ROZLYTREK | entrectinib | 50242-091 | FERRIC OXIDE YELLOW | 2038-07-18 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ENTRECTINIB
Excipient focus: ANHYDROUS LACTOSE
ENTRECTINIB drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ENTRECTINIB drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
ENTRECTINIB drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ENTRECTINIB drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ENTRECTINIB drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ENTRECTINIB drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
ENTRECTINIB drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
ENTRECTINIB drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ENTRECTINIB drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
ENTRECTINIB drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ENTRECTINIB drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | entrectinib | 50242-091 |
| >Company | >Ingredient | >NDC |
ENTRECTINIB drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
